PHARMACOKINETICS OF VARIOUS SINGLE INTRAVENOUS AND ORAL DOSES OF OMEPRAZOLE

被引:46
|
作者
ANDERSSON, T
CEDERBERG, C
REGARDH, CG
SKANBERG, I
机构
[1] Research Laboratories, Mölndal, AB Hässle
关键词
bioavailability; dose-dependent kinetics; metabolites; Omeprazole; pharmacokinetics;
D O I
10.1007/BF00280061
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The influence of dose on the kinetics of omeprazole and two of its metabolites, hydroxyomeprazole and the sulphone, has been studied. Ten healthy subjects were given omeprazole 10 and 40 mg iv and 10, 40 and 90 mg orally. No significant dose-related difference in any parameter calculated from the iv experiments was detected. Following the oral solutions, however, there was a dose-dependent increase in systemic availability, probably due to saturable first-pass elimination. The AUC of the sulphone also seemed to increase non-linearly with increasing dose, and that of the hydroxyomeprazole increased in proportion to dose. The slight dose-dependency of the bioavailability of the solution is considered to be of no or limited clinical relevance. Furthermore, since omeprazole is given orally as slowly absorbed enteric coated granules in the dose of 20 mg o.d., the potential for dose-dependent kinetics in clinical practice would be much less than in the present study. © 1990 Springer-Verlag.
引用
收藏
页码:195 / 197
页数:3
相关论文
共 50 条
  • [1] THE PHARMACOKINETICS OF OMEPRAZOLE IN HUMANS - A STUDY OF SINGLE INTRAVENOUS AND ORAL DOSES
    REGARDH, CG
    ANDERSSON, T
    LAGERSTROM, PO
    LUNDBORG, P
    SKANBERG, I
    [J]. THERAPEUTIC DRUG MONITORING, 1990, 12 (02) : 163 - 172
  • [2] PHARMACOKINETICS OF AZAPROPAZONE FOLLOWING SINGLE ORAL AND INTRAVENOUS DOSES
    BREUING, KH
    GILFRICH, HJ
    MEINERTZ, T
    JAHNCHEN, E
    [J]. ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1979, 29-1 (06): : 971 - 972
  • [3] PHARMACOKINETICS OF LOXIGLUMIDE AFTER SINGLE INTRAVENOUS OR ORAL DOSES IN MAN
    SETNIKAR, I
    CHISTE, R
    MAKOVEC, F
    ROVATI, LC
    WARRINGTON, SJ
    [J]. ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1988, 38-1 (05): : 716 - 720
  • [4] Pharmacokinetics of phenylbutazone in llamas following single intravenous and oral doses
    Navarre, CB
    Ravis, WR
    Nagilla, R
    Simpkins, A
    Duran, SH
    Pugh, DG
    [J]. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2001, 24 (03) : 227 - 231
  • [5] SINGLE INTRAVENOUS AND ORAL DOSES OF FENFLUMIZOLE - PHARMACOKINETICS AND EFFECTS ON PROSTANOID FORMATION
    VINGE, E
    ARNOLD, E
    RASMUSSEN, SN
    MIDSKOV, C
    [J]. ACTA PHARMACOLOGICA ET TOXICOLOGICA, 1985, 57 (02): : 121 - 129
  • [6] PHARMACOKINETICS OF CIPROFLOXACIN - INTRAVENOUS AND INCREASING ORAL DOSES
    BERGAN, T
    THORSTEINSSON, SB
    SOLBERG, R
    BJORNSKAU, L
    KOLSTAD, IM
    JOHNSEN, S
    [J]. AMERICAN JOURNAL OF MEDICINE, 1987, 82 (4A): : 97 - 102
  • [7] EFFECT OF FAMOTIDINE ON CIPROFLOXACIN PHARMACOKINETICS AFTER SINGLE INTRAVENOUS AND ORAL DOSES IN RATS
    ALKHAMIS, KI
    JIM, LK
    BAWAZIR, SA
    ASHOUR, LF
    ELSAYED, N
    ELSAYED, YM
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 1994, 19 (06) : 335 - 339
  • [8] Pharmacokinetics of single intravenous and oral doses of dolasetron mesylate in healthy elderly volunteers
    Dempsey, E
    Bourque, S
    Spenard, J
    Landriault, H
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 36 (10): : 903 - 910
  • [9] Pharmacokinetics and safety of single intravenous and oral doses of dolasetron mesylate in healthy women
    Keung, ACF
    Landriault, H
    Lefebvre, M
    Gossard, D
    Dempsey, EE
    Juneau, M
    Dimmitt, D
    Castles, M
    Roberts, L
    Spenard, J
    [J]. BIOPHARMACEUTICS & DRUG DISPOSITION, 1997, 18 (04) : 361 - 369
  • [10] SAFETY AND PHARMACOKINETICS OF SINGLE ORAL AND INTRAVENOUS DOSES OF FLUCONAZOLE IN HEALTHY-SUBJECTS
    SHIBA, K
    SAITO, A
    MIYAHARA, T
    [J]. CLINICAL THERAPEUTICS, 1990, 12 (03) : 206 - 215